EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?

Valdete Regina Guandalini, Patrícia Silva Tofani, Sara Souza Lima, Letícia Coelho Silveira, Natália Cochar-Soares, Thais Barros Pereira da Silva, Thales Batista de Souza, Mariane Marques Luiz, Paula Camila Ramírez, Roberta de Oliveira Máximo, Andrew Steptoe, Cesar de Oliveira und 1 weitere

Aging Clinical and Experimental Research · 2024

DOI: 10.1007/s40520-024-02866-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Clinical and Experimental Research, 2024. Verfasst von Valdete Regina Guandalini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Health Postgraduate Program, Federal University of Vitoria, Vitoria, Brazil. Hauptthemen laut MEDLINE: Sarcopenia, Obesity, Abdominal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenic obesity is a condition where loss of muscle mass occurs alongside fat gain, and it is considered a risk factor for mortality. However, the use of various definitions for this condition has led to conflicting results.

Aim

To investigate whether the coexistence of low muscle mass and abdominal obesity, defined using two simple measures employed in clinical practice, is a risk factor for mortality in individuals aged 50 or older.

Methods

A longitudinal study with a 14-year follow-up was conducted involving 5,440 participants of the English Longitudinal Study of Ageing . Abdominal obesity and low muscle mass were respectively defined based on high waist circumference and low skeletal muscle mass index (SMMI) determined by an equation. The sample was divided into four groups: non-low muscle mass/non-abdominal obesity (NLMM/NAO), non-low muscle mass/abdominal obesity (NLMM/AO), low muscle mass/non-abdominal obesity (LMM/NAO), and low muscle mass/abdominal obesity (LMM/AO). Cox regression models were used to estimate the mortality risk as a function of muscle mass and abdominal obesity status.

Results

LMM/AO increased the risk of death by 83% (HR:1.83; 95%CI: 1.35–2.66) compared to those in the NLMM/NAO group. AO alone was not associated with a greater risk of mortality (HR:1.09; 95%CI: 0.93–1.27), whereas LMM alone increased the risk by 40% (HR:1.40; 95%CI:1.18–1.66).

Conclusions

Identifying LMM/AO in individuals aged 50 or older can be crucial for predicting the risk of mortality. Simple and easily applicable measures can serve as a proxy for sarcopenic obesity and aid in implementing the necessary interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaObesity, AbdominalHumansMaleFemaleAgedMiddle AgedLongitudinal StudiesRisk FactorsWaist CircumferenceObesityMuscle, SkeletalAged, 80 and over

Stichwörter der Autor:innen

MortalityMuscle massOlder adultsSarcopeniaVisceral obesity

Autor:innen und Institutionen

  • Nutrition and Health Postgraduate Program, Federal University of Vitoria, Vitoria, Brazil.
  • Gerontology Postgraduate Program, Federal University of Sao Carlos, Sao Carlos, Brazil.
  • Department of Physical Therapy, Federal University of Sergipe, Lagartos, Brazil.
  • Physical Therapy Postgraduate Program, Federal University of Sao Carlos, Sao Carlos, Brazil.
  • Escuela de Fisioterapia, Universidad Industrial de Santander, Bucaramanga, Colombia.
  • Department of Epidemiology and Public Health, University College London, London, UK.

Förderung

  • NIA NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • National Institute on Aging

Zitieren

APA

Guandalini, V. R., Tofani, P. S., Lima, S. S., Silveira, L. C., Cochar-Soares, N., da Silva, T. B. P., de Souza, T. B., Luiz, M. M., Ramírez, P. C., de Oliveira Máximo, R., Steptoe, A., de Oliveira, C., & da Silva Alexandre, T. (2024). Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-024-02866-9

Vancouver

Guandalini VR, Tofani PS, Lima SS, Silveira LC, Cochar-Soares N, da Silva TBP, et al. Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?. Aging Clinical and Experimental Research. 2024. doi:10.1007/s40520-024-02866-9

BibTeX
@article{Guandalini2024,
  author = {Guandalini, Valdete Regina and Tofani, Patrícia Silva and Lima, Sara Souza and Silveira, Letícia Coelho and Cochar-Soares, Natália and da Silva, Thais Barros Pereira and de Souza, Thales Batista and Luiz, Mariane Marques and Ramírez, Paula Camila and de Oliveira Máximo, Roberta and Steptoe, Andrew and de Oliveira, Cesar and da Silva Alexandre, Tiago},
  title = {Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?},
  journal = {Aging Clinical and Experimental Research},
  year = {2024},
  doi = {10.1007/s40520-024-02866-9}
}
Kostenlos starten →